Criticism spiral over Chinese nepo baby privilege
The impact was swift and severe. Her name was removed from the cast list of the TV drama Lychees in Chang'an, and several brand partnerships quickly dissolved. Nashi became the latest public figure in China to come under fire as public sentiment increasingly turns against those perceived to benefit unfairly from privilege. To ease the mounting discontent, authorities have responded with formal investigations.
Over recent months, several high-profile cases have captured attention, involving not just actresses but also a Harvard alumna and a prominent doctor from a leading Beijing hospital. All were young women accused of using influential family ties to bypass merit-based systems.
“There’s privilege every year, but this year there’s more than ever,” commented one user on the microblogging platform Weibo. Another user added, “I would love to see more scandals like this. They are truly eye-opening.”
Research indicates that as unemployment rises and economic growth slows, many young people in China feel disillusioned—believing that success now depends more on personal connections, or guanxi, than on effort or achievement.
In Nashi’s case, critics allege she exploited her mother’s standing in the entertainment industry to gain admission into an elite drama academy. The institution in question offered a program specifically for ethnic Mongolian students, a category that included both Nashi and her mother, who also attended the same school during the 1980s.
The controversy intensified when past interview footage emerged in which Nashi admitted she had not met one of the program’s key conditions—returning to serve in Inner Mongolia after graduation. Instead, she left China to continue her studies in Norway, a decision that fueled further accusations of exploiting a system designed to benefit underrepresented communities.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
